Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03991741Phase 1Terminated
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Locally Advanced Refractory/Recurrent Head and Neck CancerLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more
PrincipalinvestigatorStart date: 2020-10-07
NCT00925314Phase 2Unknown
A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ezra Cohen, MD

University of California, San Diego

Moderately Similar
4 trials

Shared therapeutic areas:

Locally Advanced Refractory/Recurrent Head and Neck CancerLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more

Worked with same sponsors:

Gregory DanielsImmunotherapy Foundation
Collaborated on 1 trial
Similarity Score44%

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Similarity Score10%

Kunle Odunsi

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Similarity Score10%

Amod Sarnaik, M.D.

H. Lee Moffitt Cancer Center and Research Institute

Related
4 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

James C Yang, M.D.

National Cancer Institute (NCI)

Related
7 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

Antoni Ribas, MD

University of California, Los Angeles

Related
2 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03991741Phase 1PrincipalInvestigator

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Locally Advanced Refractory/Recurrent Head and Neck CancerLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more
Terminated
NCT00925314Phase 2PrincipalInvestigator

A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma

Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Unknown

All 2 trials loaded